三生制药2024年年度业绩点评:核心品种推动业绩稳健增长,管线与合作助力未来增量

民生证券
28 Mar

业绩稳步攀升。2025年3月25日,三生制药发布2024年年度业绩公告,2024年公司实现收入91.1亿元,同比增长16.5%;实现毛利78.3亿元,同比增长17.9%;实现归母净利润20.9亿元,同比增长34.9%;实现扣非归母净利润23.2亿元,同比增长18.8%。核心品种推动业绩稳健增长,管线与合作助力未来增量业绩稳步攀升。2025年3月25日,三生制药发布2024年年度业绩公告,2024年...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10